Romosozumab Use and Cardiovascular Events
- PMID: 36127855
- DOI: 10.1002/jbmr.4695
Romosozumab Use and Cardiovascular Events
Comment in
-
Reply to Letter to the Editor: Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.J Bone Miner Res. 2023 Feb;38(2):356. doi: 10.1002/jbmr.4761. Epub 2023 Jan 25. J Bone Miner Res. 2023. PMID: 36698050 No abstract available.
Comment on
-
Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.J Bone Miner Res. 2022 Aug;37(8):1437-1445. doi: 10.1002/jbmr.4563. Epub 2022 May 20. J Bone Miner Res. 2022. PMID: 35466448 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources